Friday, March 29, 2019

MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE) Subsidiary Offers Innovative POS Solutions to Restaurant Industry

Global technology and value-added solutions group Net Element (NASDAQ: NETE), through its wholly owned subsidiary Aptito, delivers comprehensive business-management solutions and cloud-based point of sale (“POS”) for the restaurant industry. A recent article discussing the company reads, “A quality POS system ensures quality service, whether it’s used in a gourmet restaurant or a quick service restaurant (http://ibn.fm/kVM5c). In the second case, customers are looking for quick services and convenience, and having to wait for a payment to be processed takes away from that experience. . . . Innovative POS solutions like those provided by Aptito are also a good choice for small restaurants, startups and businesses trying to establish their market positions with limited budgets.”
To view the full article, visit http://ibn.fm/X7LHG
About Net Element Inc.
Net Element (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500. In 2017, Net Element was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Utilizes Disruptive Technology for Improved Delivery of Bioactive Compounds

Biotechnology company and drug-delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) utilizes disruptive technology for the improved delivery of bioactive compounds. A recent article discussing this reads, “Lexaria’s technology has been shown to be effective in numerous global studies, significantly assisting rapidity and quantity of absorption for a range of lipophilic (fat-soluble), bioactive molecules. In essence, the company disrupts the manner in which cannabinoids enter the bloodstream through the gastrointestinal tract (http://ibn.fm/CsUCz). Lexaria’s emphasis on oral ingestion provides a practical and often healthier option to other delivery methods for bioactive substances used extensively today. This includes inhalational delivery via smoking.”
To view the full article, visit http://ibn.fm/iWJQP
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

As Cannabidiol-Infused Beverage Market Grows, Youngevity International Inc. (NASDAQ: YGYI) Launches Two Relevant Products

  • The two new cannabidiol-infused coffee brands from Youngevity are expected to become available in May, allowing the company the opportunity to establish a solid presence within the expanding market
  • The first brand, HempFX, will be a direct sales product, while Javalution is set to become available later in May for retail store distribution
  • The company is cultivating a market that appeals to the over 100 million coffee drinkers in the U.S. who are also aware of the benefits of cannabidiol-infused beverages
The U.S. market for cannabidiol-infused beverages is expanding rapidly, with forecasts calling for a valuation of $260 million by 2022. The revenue from such products could outpace all other industry representatives, capturing almost 20 percent of the edibles market by 2022, per industry data (http://ibn.fm/mOUIV).
There are several reasons for the growing popularity of such beverages. Legalization measures in the U.S. are the first and most prominent reason why the market is anticipated to grow. In addition, consumers are becoming more conscious of healthy choices, substituting typical beverages with much more beneficial options (http://ibn.fm/oJLig).
Addressing the market dynamics and seizing the new opportunities, companies like Youngevity International Inc. (NASDAQ: YGYI) are announcing innovative developments designed to provide health-conscious customers with more options.
Youngevity is catering to a market of over 100 million Americans who drink coffee and are aware of the numerous health benefits resulting from the consumption of cannabidiol-infused beverages. In March 2019, the company announced the development and launch of two infused coffee brands.
As per the official announcement, sale of the new coffee brands is anticipated to start in May 2019. HempFX will be a direct sales product that will be available through the Youngevity distribution and sales network. Youngevity’s subsidiary, CLR Roasters, anticipates the rollout of its Javalution brand later in May for retail store distribution. The retail sales presentation for Javalution has already started (http://ibn.fm/043id).
Both of the brands will offer coffee lovers four flavor profiles – Dark Roast, Donut Shop, French Vanilla and House Blend. Each one will be available as a single-serve product that delivers 10 milligrams of cannabidiol per cup of coffee.
According to Youngevity president and CFO Dave Briskie, delivering water-soluble cannabidiol in consistent doses has been a challenge that the company managed to overcome. The currently utilized solution passes laboratory testing to ensure consistent delivery of the beverage’s cannabidiol content.
The development became possible through the work of the Youngevity team at Khrysos Global – a Florida-based manufacturer of hemp-based cannabidiol extraction equipment. Youngevity acquired Khrysos in February, gaining ownership of INX Labs and the Khrysos testing facilities.
The water-soluble cannabidiol infusion technology is deliverable in both powders and liquids. This fact provides Youngevity with the opportunity to continue exploring the cannabidiol beverage and food markets, launching new products in the future.
Youngevity International is a leading omni-direct lifestyle company that emphasizes a hybrid model of direct selling and social selling. It has been included among the top 100 global direct selling companies. Youngevity offers products in the top eight selling retail categories, which include health and nutrition, home and family, food and beverage, spa and beauty, fashion, essential oils, photo and innovative services.
For more information, visit the company’s website at www.YGYI.com
NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html